Effectiveness of nonpharmacological secondary prevention of coronary heart disease
Falk Müller‐Riemenschneider(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Stefan N. Willich(Humboldt-Universität zu Berlin), Angelina Bockelbrink(Charité - Universitätsmedizin Berlin), Charlotte Meinhard(University Medical Center), Wolfgang Greiner(Bielefeld University), Kathrin Damm(Leibniz University Hannover), Christoph Vauth(Leibniz University of Applied Sciences)
European Journal of Cardiovascular Prevention & Rehabilitation
May 7, 2010
Cited by 59
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
Obesity prevalence from a European perspective: a systematic review
|BMC Public Health|2008|740
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618